- Home
- Products
- Customized FluoroAb™
- APP
- Ponezumab-iFluor 568
Ponezumab-iFluor 568 (CAT#: ADC-FL-187)
This product is comprised of an anti-APP monoclonal antibody (Ponezumab) labeled with iFluor 568. iFluor 568 is a orange-fluorescent dye and it's excitation/emission is 578/603 nm.
- TARGET
- ANTIBODY
- DYE
- Name
- APP
- Alternative Names
- APP; amyloid beta (A4) precursor protein; AD1, Alzheimer disease; amyloid beta A4 protein; peptidase nexin II; preA4; protease nexin-II; peptidase nexin-II; beta-amyloid peptide; alzheimer disease amyloid protein; cerebral vascular amyloid peptide; AAA; AD1; PN2; ABPP; APPI; CVAP; ABETA; PN-II; CTFgamma;
- Overview
- This gene encodes a cell surface receptor and transmembrane precursor protein that is cleaved by secretases to form a number of peptides. Some of these peptides are secreted and can bind to the acetyltransferase complex APBB1/TIP60 to promote transcriptional activation, while others form the protein basis of the amyloid plaques found in the brains of patients with Alzheimer disease. In addition, two of the peptides are antimicrobial peptides, having been shown to have bacteriocidal and antifungal activities. Mutations in this gene have been implicated in autosomal dominant Alzheimer disease and cerebroarterial amyloidosis (cerebral amyloid angiopathy). Multiple transcript variants encoding several different isoforms have been found for this gene.
- Overview
- Humanized Anti-APP IgG2-kappa antibody, Ponezumab
- Generic name
- Ponezumab
- Species Reactivity
- Human
- Name
- iFluor 568
- Color
- Orange
- Excitation⁄Emission (nm)
- 578/603
- Detection method
- Fluorescent
For Research Use Only. NOT FOR CLINICAL USE.
Related Products
- Anti-IGF2 MAb (Clone 3)-iFluor® 555 Succinimidyl Ester (CAT#: WJY0-LS16675)
- Anti-CD70 MAb (Clone 11)-iFluor® 460 Succinimidyl Ester (CAT#: WJY0-LS8564)
- Anti-IFNA1 MAb (Clone 4)-iFluor® 555 Succinimidyl Ester (CAT#: WJY0-LS16656)
- Anti-LYPD3 MAb (Clone 4)-iFluor® 532 Succinimidyl Ester (CAT#: WJY0-LS13221)
- Anti-ERBB2 MAb (Clone 24)-iFluor® 514 Succinimidyl Ester (CAT#: WJY0-LS11313)
- Anti-MSLN MAb (Clone 8)-iFluor® 488 Succinimidyl Ester (CAT#: WJY0-LS10233)
- Tregalizumab-iFluor 680 (CAT#: ADC-FL-676)
- Anti-CD19 MAb (Clone 32)-iFluor® 350 Succinimidyl Ester (CAT#: WJY0-LS938)
- Anti-IL22 MAb (Clone 1)-iFluor® 488 Succinimidyl Ester (CAT#: WJY0-LS9854)
- Anti-191P4D12 MAb (Clone 1)-iFluor® 440 Succinimidyl Ester (CAT#: WJY0-LS4880)
Published Data
+ Submit Publications
Scientific Resources
Customer Reviews and FAQs
There are currently no Customer reviews or questions for ADC-FL-187. Click the button above to contact us or submit your feedback about this product.
Quick Links
Other Products
Same Target
| CAT# | Product Name | Linker | Payload |
| ADC-W-707 | Anti-APP (Bapineuzumab)-MC-Vc-PAB-MMAE ADC | MC-Vc-PAB (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl) | MMAE |
| ADC-W-715 | Anti-APP (Ponezumab)-MC-Vc-PAB-DMEA-(PEG2)-duocarmycin SA ADC | MC-Vc-PAB-DMEA-(PEG2) | duocarmycin SA |
| ADC-W-705 | Anti-APP (Bapineuzumab)-SPDB-DM4 ADC | SPDB (N-succinimidyl-4-(2-pyridyldithio)butyrate) | DM4 (N2'-Deacetyl-N2'-(4-mercapto-4-methyl-1-oxopentyl)maytansine) |
| ADC-W-710 | Anti-APP (Ponezumab)-SMCC-DM1 ADC | SMCC (N-succinimidyl 4-(Nmaleimidomethyl)cyclohexane-1-carboxylate) | DM1 (N2'-Deacetyl-N2'-(3-mercapto-1-oxopropyl)maytansine) |
| ADC-W-703 | Anti-APP (Solanezumab)-MC-Vc-PAB-DMEA-(PEG2)-duocarmycin SA ADC | MC-Vc-PAB-DMEA-(PEG2) | duocarmycin SA |
Online Inquiry
Welcome! For price inquiries, please feel free to contact us through the form on the left side. We will get back to you as soon as possible.
